thiazoles has been researched along with ponatinib in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clackson, T; Deininger, MW; Druker, BJ; Eide, CA; O'Hare, T | 1 |
| Quintás-Cardama, A; Santos, FP | 1 |
| Pfirrmann, M; Saussele, S | 1 |
| Kantarjian, H; Liu-Dumlao, T; O'Brien, S; Ravandi, F; Thomas, DA | 1 |
| Azam, M | 1 |
| Auberger, P; Cassuto, JP; Cassuto, O; Dubois, A; Dufies, M; Ginet, C; Hamouda, A; Jacquel, A; Karsenti, JM; Legros, L; Lenain, P; Luciano, F; Puissant, A; Robert, G | 1 |
| Dolgin, E | 1 |
| Tojo, A | 1 |
| Bengió, RM; Bianchini, M; Ferri, CA; Gonzalez, MS; Larripa, IB; Moiraghi, EB; Noriega, MF | 1 |
| Takahashi, N | 1 |
| Eigendorff, E; Ernst, T; Hochhaus, A; La Rosée, P | 1 |
| Kim, HH; Korade, Z; Porter, NA; Wages, PA | 1 |
5 review(s) available for thiazoles and ponatinib
| Article | Year |
|---|---|
New drugs for chronic myelogenous leukemia.
Topics: Benzamides; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Thiazoles | 2011 |
Clinical trials in chronic myeloid leukemia.
Topics: Aniline Compounds; Benzamides; Dasatinib; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nitriles; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridazines; Pyrimidines; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Survival Analysis; Thiazoles | 2012 |
Philadelphia-positive acute lymphoblastic leukemia: current treatment options.
Topics: Aniline Compounds; Antineoplastic Agents; Benzamides; Dasatinib; Humans; Imatinib Mesylate; Imidazoles; Neoplasm, Residual; Nitriles; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Quinolines; Stem Cell Transplantation; Thiazoles | 2012 |
[Management of advanced stage chronic myeloid leukemia].
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Dasatinib; Disease Progression; Drug Design; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Neoplasm Staging; Piperazines; Point Mutation; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles | 2014 |
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.
Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Disease Progression; Drug Monitoring; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Mutation; Nitriles; Prognosis; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Quinolines; Thiazoles | 2015 |
7 other study(ies) available for thiazoles and ponatinib
| Article | Year |
|---|---|
Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia.
Topics: Antineoplastic Agents; Dasatinib; Drug Resistance, Neoplasm; Drugs, Investigational; Fusion Proteins, bcr-abl; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Mutation; Pyridazines; Pyrimidines; Signal Transduction; Thiazoles | 2011 |
An in vitro screening to identify drug-resistant mutations for target-directed chemotherapeutic agents.
Topics: Benzamides; Cell Line; Dasatinib; Drug Discovery; Drug Evaluation, Preclinical; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Imidazoles; Mutation; Piperazines; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Thiazoles | 2012 |
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Survival; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Imidazoles; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mutation; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridazines; Pyrimidines; Signal Transduction; Thiazoles; Tumor Cells, Cultured | 2012 |
As leukemia options grow, drugs jockey to be first-line therapies.
Topics: Antineoplastic Agents; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridazines; Pyrimidines; Thiazoles | 2013 |
[Chronic myeloid leukemia].
Topics: Dasatinib; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridazines; Pyrimidines; Thiazoles | 2012 |
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.
Topics: Antineoplastic Agents; Dasatinib; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Gene Expression; Humans; Hydroxyurea; Imidazoles; Leukemia, Myeloid, Chronic-Phase; Middle Aged; Mutation; Pyridazines; Pyrimidines; RNA, Messenger; Thiazoles; Treatment Outcome | 2015 |
Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol.
Topics: Benzamides; Cell Line, Tumor; Dehydrocholesterols; Desmosterol; Drug Evaluation, Preclinical; Gene Expression Regulation; High-Throughput Screening Assays; Humans; Imidazoles; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Piperidines; Prescription Drugs; Pyridazines; Pyridines; Thiazoles; United States; United States Food and Drug Administration | 2018 |